Anavex Life Sciences Corp (AVXL)
8.63
+0.16
(+1.89%)
USD |
NASDAQ |
Dec 20, 16:00
8.65
+0.02
(+0.23%)
After-Hours: 20:00
Anavex Life Sciences Enterprise Value: 593.03M for Dec. 20, 2024
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Avid Bioservices Inc | 908.76M |
| Alaunos Therapeutics Inc | 1.566M |
| SELLAS Life Sciences Group Inc | 42.36M |
| Galectin Therapeutics Inc | 144.36M |
| Oragenics Inc | 3.306M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -12.21M |
| Total Expenses (Quarterly) | 14.73M |
| EPS Diluted (Quarterly) | -0.14 |
| Earnings Yield | -5.91% |